| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 7265146
[patent_doc_number] => 20040242682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-02
[patent_title] => 'Compositions comprising arginine and nitrates'
[patent_app_type] => new
[patent_app_number] => 10/763358
[patent_app_country] => US
[patent_app_date] => 2004-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7381
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0242/20040242682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10763358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/763358 | Compositions comprising arginine and nitrates | Jan 22, 2004 | Abandoned |
Array
(
[id] => 7201057
[patent_doc_number] => 20050165077
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-07-28
[patent_title] => 'Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage'
[patent_app_type] => utility
[patent_app_number] => 10/762616
[patent_app_country] => US
[patent_app_date] => 2004-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4154
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20050165077.pdf
[firstpage_image] =>[orig_patent_app_number] => 10762616
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/762616 | Association of fluconazole-tinidazole for the treatment of vaginal infections, its composition, preparation process and usage | Jan 21, 2004 | Issued |
Array
(
[id] => 7288377
[patent_doc_number] => 20040147552
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-29
[patent_title] => 'Methods of treating select neuronal inflammatory disorders using hydroxyalkylquinolines'
[patent_app_type] => new
[patent_app_number] => 10/755125
[patent_app_country] => US
[patent_app_date] => 2004-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4631
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20040147552.pdf
[firstpage_image] =>[orig_patent_app_number] => 10755125
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/755125 | Methods of treating select neuronal inflammatory disorders using hydroxyalkylquinolines | Jan 8, 2004 | Abandoned |
Array
(
[id] => 7256773
[patent_doc_number] => 20040259892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-12-23
[patent_title] => 'Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms)'
[patent_app_type] => new
[patent_app_number] => 10/482034
[patent_app_country] => US
[patent_app_date] => 2003-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4838
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0259/20040259892.pdf
[firstpage_image] =>[orig_patent_app_number] => 10482034
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/482034 | Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms) | Dec 28, 2003 | Abandoned |
Array
(
[id] => 6997420
[patent_doc_number] => 20050137198
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-23
[patent_title] => 'Stable hydrazalazine pharmaceutical compositions'
[patent_app_type] => utility
[patent_app_number] => 10/745232
[patent_app_country] => US
[patent_app_date] => 2003-12-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6539
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0137/20050137198.pdf
[firstpage_image] =>[orig_patent_app_number] => 10745232
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/745232 | Stable hydrazalazine pharmaceutical compositions | Dec 22, 2003 | Issued |
Array
(
[id] => 366252
[patent_doc_number] => 07479268
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-01-20
[patent_title] => 'Staining agent in tablet form for making visible the formation of dental plaque and method for producing such a staining agent'
[patent_app_type] => utility
[patent_app_number] => 10/508250
[patent_app_country] => US
[patent_app_date] => 2003-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 943
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/479/07479268.pdf
[firstpage_image] =>[orig_patent_app_number] => 10508250
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/508250 | Staining agent in tablet form for making visible the formation of dental plaque and method for producing such a staining agent | Dec 17, 2003 | Issued |
Array
(
[id] => 5760756
[patent_doc_number] => 20060211701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-21
[patent_title] => 'Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders'
[patent_app_type] => utility
[patent_app_number] => 10/539842
[patent_app_country] => US
[patent_app_date] => 2003-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11090
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0211/20060211701.pdf
[firstpage_image] =>[orig_patent_app_number] => 10539842
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/539842 | Use of von tetrahydrobiopterine derivatives in the treatment and nutrition of patients with amino acid metabolic disorders | Dec 14, 2003 | Abandoned |
Array
(
[id] => 7190546
[patent_doc_number] => 20040204411
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof'
[patent_app_type] => new
[patent_app_number] => 10/727918
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21427
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204411.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727918
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727918 | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof | Dec 3, 2003 | Abandoned |
Array
(
[id] => 7276474
[patent_doc_number] => 20040235925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-11-25
[patent_title] => 'Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof'
[patent_app_type] => new
[patent_app_number] => 10/727717
[patent_app_country] => US
[patent_app_date] => 2003-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23138
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0235/20040235925.pdf
[firstpage_image] =>[orig_patent_app_number] => 10727717
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/727717 | Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof | Dec 3, 2003 | Abandoned |
Array
(
[id] => 5683595
[patent_doc_number] => 20060199865
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-09-07
[patent_title] => 'Synergistic combination comprising roflumilast and (r,r) - formoterol'
[patent_app_type] => utility
[patent_app_number] => 10/535817
[patent_app_country] => US
[patent_app_date] => 2003-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2060
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0199/20060199865.pdf
[firstpage_image] =>[orig_patent_app_number] => 10535817
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/535817 | Synergistic combination comprising roflumilast and (r,r) - formoterol | Nov 25, 2003 | Abandoned |
Array
(
[id] => 5010413
[patent_doc_number] => 20070280892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-12-06
[patent_title] => 'Mixture With Wintergreen Odor And Flavor'
[patent_app_type] => utility
[patent_app_number] => 10/595815
[patent_app_country] => US
[patent_app_date] => 2003-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8134
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20070280892.pdf
[firstpage_image] =>[orig_patent_app_number] => 10595815
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/595815 | Mixture with wintergreen odor and flavor | Nov 11, 2003 | Issued |
Array
(
[id] => 5807209
[patent_doc_number] => 20060093563
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Oral antimicrobial composition and use thereof in treating of dental plaque and gingivitis'
[patent_app_type] => utility
[patent_app_number] => 10/532268
[patent_app_country] => US
[patent_app_date] => 2003-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3160
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0093/20060093563.pdf
[firstpage_image] =>[orig_patent_app_number] => 10532268
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/532268 | Oral antimicrobial composition and use thereof in treating of dental plaque and gingivitis | Oct 30, 2003 | Abandoned |
Array
(
[id] => 7098453
[patent_doc_number] => 20050130912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-06-16
[patent_title] => 'Compositions for the improvement of obesity'
[patent_app_type] => utility
[patent_app_number] => 10/507779
[patent_app_country] => US
[patent_app_date] => 2003-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4086
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0130/20050130912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10507779
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/507779 | Compositions for the improvement of obesity | Oct 20, 2003 | Abandoned |
Array
(
[id] => 5913754
[patent_doc_number] => 20060128792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-15
[patent_title] => 'Deguelin as a chemopreventive agent for lung cancer'
[patent_app_type] => utility
[patent_app_number] => 10/531140
[patent_app_country] => US
[patent_app_date] => 2003-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 26641
[patent_no_of_claims] => 121
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0128/20060128792.pdf
[firstpage_image] =>[orig_patent_app_number] => 10531140
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/531140 | Deguelin as a chemopreventive agent for lung cancer | Oct 9, 2003 | Abandoned |
Array
(
[id] => 7446426
[patent_doc_number] => 20040067254
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-08
[patent_title] => 'Paroxetine compositions and processes for making the same'
[patent_app_type] => new
[patent_app_number] => 10/678082
[patent_app_country] => US
[patent_app_date] => 2003-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6252
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0067/20040067254.pdf
[firstpage_image] =>[orig_patent_app_number] => 10678082
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/678082 | Paroxetine compositions and processes for making the same | Oct 5, 2003 | Abandoned |
Array
(
[id] => 7474416
[patent_doc_number] => 20040122048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-24
[patent_title] => 'Stabilized pharmaceutical composition containing basic excipients'
[patent_app_type] => new
[patent_app_number] => 10/675161
[patent_app_country] => US
[patent_app_date] => 2003-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 8009
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20040122048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10675161
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/675161 | Stabilized pharmaceutical composition containing basic excipients | Sep 29, 2003 | Abandoned |
Array
(
[id] => 5649873
[patent_doc_number] => 20060135608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-22
[patent_title] => 'Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia'
[patent_app_type] => utility
[patent_app_number] => 10/528114
[patent_app_country] => US
[patent_app_date] => 2003-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4170
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0135/20060135608.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528114
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528114 | Eicosapentaenoic acid (epa) for treating anorexia nervosa (an) and bulimia | Sep 15, 2003 | Abandoned |
Array
(
[id] => 303679
[patent_doc_number] => 07534818
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-05-19
[patent_title] => 'Method of reducing alopecia and bladder toxicity of cyclophosphamide'
[patent_app_type] => utility
[patent_app_number] => 10/663109
[patent_app_country] => US
[patent_app_date] => 2003-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 2363
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/534/07534818.pdf
[firstpage_image] =>[orig_patent_app_number] => 10663109
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/663109 | Method of reducing alopecia and bladder toxicity of cyclophosphamide | Sep 14, 2003 | Issued |
Array
(
[id] => 5590480
[patent_doc_number] => 20060039931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Stable cream preparations of phenyl-pyridone compounds for topical application'
[patent_app_type] => utility
[patent_app_number] => 10/527555
[patent_app_country] => US
[patent_app_date] => 2003-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3905
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20060039931.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527555
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527555 | Stable cream preparations of phenyl-pyridone compounds for topical application | Sep 10, 2003 | Abandoned |
Array
(
[id] => 5875488
[patent_doc_number] => 20060167069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-27
[patent_title] => 'Pharmaceutical composition of metaxalone with enhanced oral bioavailability'
[patent_app_type] => utility
[patent_app_number] => 10/526285
[patent_app_country] => US
[patent_app_date] => 2003-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3222
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20060167069.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526285
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526285 | Pharmaceutical composition of metaxalone with enhanced oral bioavailability | Sep 1, 2003 | Abandoned |